Results 21 to 30 of about 1,688,643 (309)

Opportunities and Challenges of Surveillance for Liver Cancer in Primary Care Institutions in China [PDF]

open access: yesZhongguo quanke yixue, 2023
Primary liver cancer (PLC) is one of the common malignant tumors and the main causes of tumor death in China. Although the diagnosis and treatment technology of PLC in China has made great progress in recent years, its morbidity and mortality have been ...
WANG Shiyue, DONG Chen, CHANG Chudi, NAN Yuemin
doaj   +1 more source

Liver fibrosis [PDF]

open access: yesVnitřní lékařství, 2020
Liver fibrosis is the excessive deposition of extracellular matrix in liver tissue resulting in structural and functional liver changes. The basis for these changes is the imbalance between fibrogenesis and fibrolysis, which arises in response to chronic liver damage, regardless of its aetiology.
openaire   +2 more sources

Hypoxia-induced factor and its role in liver fibrosis [PDF]

open access: yesPeerJ, 2022
Liver fibrosis develops as a result of severe liver damage and is considered a major clinical concern throughout the world. Many factors are crucial for liver fibrosis progression.
Jan Mohammad Omar, Yang Hai, Shizhu Jin
doaj   +2 more sources

Inflammasomes in Liver Fibrosis [PDF]

open access: yesSeminars in Liver Disease, 2017
AbstractCell death and inflammation are two central elements in the development of liver fibrosis. Inflammasomes are intracellular multiprotein complexes expressed in both hepatocytes and nonparenchymal cells in the liver that are key regulators of inflammation and cell fate.
Alegre F, Pelegrin P, Feldstein AE
openaire   +3 more sources

Animal and Organoid Models of Liver Fibrosis

open access: yesFrontiers in Physiology, 2021
Liver fibrosis refers to the process underlying the development of chronic liver diseases, wherein liver cells are repeatedly destroyed and regenerated, which leads to an excessive deposition and abnormal distribution of the extracellular matrix such as ...
Yu-long Bao   +10 more
doaj   +1 more source

NOX in liver fibrosis [PDF]

open access: yesArchives of Biochemistry and Biophysics, 2007
NADPH oxidase is a multi-protein complex producing reactive oxygen species (ROS) both in phagocytic cells, being essential in host defense, and in non-phagocytic cells, regulating intracellular signalling. In the liver, NADPH oxidase plays a central role in fibrogenesis.
Samuele, De Minicis, David A, Brenner
openaire   +2 more sources

TNFα in Liver Fibrosis [PDF]

open access: yesCurrent Pathobiology Reports, 2015
Hepatocyte death, inflammation, and liver fibrosis are the hallmarks of chronic liver disease. Tumor necrosis factor-α (TNFα) is an inflammatory cytokine involved in liver inflammation and sustained liver inflammation leads to liver fibrosis. TNFα exerts inflammation, proliferation, and apoptosis.
Yang, Yoon Mee, Seki, Ekihiro
openaire   +4 more sources

In Vivo and In Vitro Models to Study Liver Fibrosis: Mechanisms and LimitationsSummary

open access: yesCellular and Molecular Gastroenterology and Hepatology, 2023
Liver fibrosis is a common result of liver injury owing to various kinds of chronic liver diseases. A deeper understanding of the pathophysiology of liver fibrosis and identifying potential therapeutic targets of liver fibrosis is important because liver
Young-Sun Lee, Ekihiro Seki
doaj   +1 more source

Inhibiting IRE1α-endonuclease activity decreases tumor burden in a mouse model for hepatocellular carcinoma

open access: yeseLife, 2020
Hepatocellular carcinoma (HCC) is a liver tumor that usually arises in patients with cirrhosis. Hepatic stellate cells are key players in the progression of HCC, as they create a fibrotic micro-environment and produce growth factors and cytokines that ...
Nataša Pavlović   +6 more
doaj   +1 more source

Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease

open access: yesDiagnostics, 2021
Liver fibrosis predicts liver-related and cardiovascular outcomes in chronic liver disease patients. We compared the diagnostic performance of various liver fibrosis biomarkers for identifying histological significant/advanced fibrosis. Additionally, the
Stefano Ballestri   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy